29 C
Abuja

New HIV Vaccine Goes On Trial In South Africa

Advertisement

Related

Advertisement
Advertisement
1min read

hiv-vaccine-trial-begins-in-south-africa


A new vaccine against HIV, the virus that causes AIDS, is being tested in South Africa in what scientists say is the first large study of an HIV vaccine’s effectiveness since 2009.

The study aims to enrol 5,400 sexually active young men and women.

About seven million people in South Africa are living with the virus, which is one reason why the trial is taking place there.

Experts hope the vaccine will be “the final nail in the coffin” for HIV.

The vaccine regime being tested is based on one used in a trial in Thailand in 2009, which had a protection rate of about 30%. Results from South Africa are expected in four years.

Since the HIV virus was identified in 1983, efforts to develop an effective vaccine have proved unsuccessful.

- Advertisement -

Researchers are hoping that this might come to an end with the current study, which is code-named HVTN 702.

It is being led by South Africa’s Glenda Gray, a university research professor and head of South Africa’s Medical Research Council.

“It will tell us whether the initial success observed [at a smaller scale] will bear fruit in the form of a safe and effective HIV vaccine designed for the people of southern Africa,” Gray said.

AIDS remains the biggest cause of death among young people in Africa

According to the United Nations, more than 30 million people have died from AIDS since the 1980s.

Recent breakthroughs in anti-retroviral treatments have improved the lifespan of AIDS patients.

However, the only effective prevention remains abstinence or the use of barrier methods such as condoms during sexual intercourse.

- Advertisement -

As part of the present trial, study participants will receive a total of five injections over one year, says the US National Institutes of Health, NIH, which is sponsoring the trial.

Participants who become infected with HIV during the trial will be referred to local medical providers for care and treatment, NIH adds.

They will be advised on how to reduce their risk of transmitting the virus.

Support the ICIR

We invite you to support us to continue the work we do.

Your support will strengthen journalism in Nigeria and help sustain our democracy.

[molongui_author_box]

If you or someone you know has a lead, tip or personal experience about this report, our WhatsApp line is open and confidential for a conversation

Advertisement

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Support the ICIR

We need your support to produce excellent journalism at all times.

Advertisement

Recent

2023: With me as candidate PDP is assured of victory in Kwara – Former ambassador to Japan 

By Dare Akogun A FORMER Nigerian ambassador to Japan Yisa Gana has declared that the...

Buhari appoints Adeyemi as Statistician-General of the Federation

PRESIDENT Muhammadu Buhari has approved the appointment of Semiu Adeyemi Adeniran as the substantive...

Lagos police parade sound engineer’s suspected killers

THE Lagos Police Command has paraded six persons over the death of a sound...

NRC cancels resumption of Abuja-Kaduna train services

THE Nigerian Railway Corporation (NRC) has cancelled the planned resumption of train services along...

FCT minister seeks Rotary’s partnership in campaign to end open defecation

THE Minister of State for the Federal Capital Territory, Ramatu Tijjani, has asked Rotary...
Advertisement

Most Read

Advertisement

Subscribe to our newsletter

Advertisement